tetano
Editor, Senior Moderator
Trends Microbiol. 2017 Dec 18. pii: S0966-842X(17)30276-7. doi: 10.1016/j.tim.2017.12.003. [Epub ahead of print]
[h=1]Influenza H3N2 Vaccines: Recent Challenges.[/h] Mostafa A[SUP]1[/SUP], Pleschka S[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] H3N2-subtype influenza A viruses are major causes of seasonal influenza epidemics. Emerging H3N2 variants require the annual adjustment of the vaccine strain. Recently, studies addressing the reduced effectiveness of current H3N2 vaccines have identified production-related substitutions in the viral hemagglutinin antigen as a possible cause for reduced vaccine efficacy.
[h=4]KEYWORDS:[/h] H3N2 subtype; HA glycosylation; influenza vaccine; influenza virus
PMID: 29268980 DOI: 10.1016/j.tim.2017.12.003
[h=1]Influenza H3N2 Vaccines: Recent Challenges.[/h] Mostafa A[SUP]1[/SUP], Pleschka S[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] H3N2-subtype influenza A viruses are major causes of seasonal influenza epidemics. Emerging H3N2 variants require the annual adjustment of the vaccine strain. Recently, studies addressing the reduced effectiveness of current H3N2 vaccines have identified production-related substitutions in the viral hemagglutinin antigen as a possible cause for reduced vaccine efficacy.
[h=4]KEYWORDS:[/h] H3N2 subtype; HA glycosylation; influenza vaccine; influenza virus
PMID: 29268980 DOI: 10.1016/j.tim.2017.12.003